Amtech Systems, Inc., a global supplier of production and automation systems and related supplies for the manufacture of solar cells, semiconductors, and silicon wafers, today announced that it has booked over $100 million in orders for its solar and semiconductor products in fiscal 2008 ended September 30th, with solar orders approximating 70% of total bookings.
Elpida Memory, Inc., Japan's leading global supplier of Dynamic Random Access Memory (DRAM), announced today that it has developed a shrunken version of its 1-gigabit DDR2 SDRAM that delivers 20% more chips from a single 300mm wafer.
Nerac Medical Device Analyst Perry De Fazio will discuss how medical device companies can assess whether a new technology will disrupt the market during a MDM Webinar on Oct. 8, 2008. He also will reveal how companies can identify emerging technologies that present potential business opportunities.
Cellular studies are revolutionized with the launch of new software from Carl Zeiss that automatically extracts biologically relevant data from micrographs by combining high-resolution fluorescence imaging and complex image analysis.
Microfluidics, a division of Microfluidics International Corporation, has announced that the company's CTO and nationally renowned nanotechnology applications expert, Thomai Panagiotou, Ph.D, will be presenting a talk at the 2008 National Nano Engineering Conference, November 12 and 13 in Boston.
IMEC, Europe's leading independent nanoelectronics research institute, and Taiyo Nippon Sanso Corp. (TNSC), a total solution provider in the compound semiconductor field, today announced that they have signed an agreement to jointly develop manufacturing technology for high efficiency LED devices.
Minerva Biotechnologies, a leading nanotechnology, cancer and stem cell development company today announced a major breakthrough in stem cell research. Minerva and collaborators at the University of California at Santa Barbara discovered that a single, new growth factor can not only support massive growth of human embryonic stem cells (hESCs) in vitro, but also maintains them in a nearly 100% undifferentiated state without the need for fibroblast "'eeder cells'.